2,5-Dihydro-2,5-dioxo-N-[3-[3-(trifluoromethyl)-3H-diazirin-3-yl]phenyl]-1H-pyrrole-1-butanamide

CAS : 151077-62-2

Ref. 3D-FD102184

Informations sur le produit

• Nom: 2,5-Dihydro-2,5-dioxo-N-[3-[3-(trifluoromethyl)-3H-diazirin-3-yl]phenyl]-1H-pyrrole-1-butanamide
• Synonymes: N-(m-(3-(Trifluoromethyl)-diazirin-3-yl)phenyl)-4-maleimidobutyramide, Tdpmb, 1H-Pyrrole-1-butanamide, 2,5-dihydro-2,5-dioxo-N-(3-(3-(trifluoromethyl)-3H-diazirin-3-yl)phenyl)-, 4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-{3-[3-(trifluoromethyl)-3H-diaziren-3-yl]phenyl}butanamide

Description

2,5-Dihydro-2,5-dioxo-N-[3-[3-(trifluoromethyl)-3H-diazirin-3-yl]phenyl]-1H-pyrrole-1-butanamide (LZP) is an experimental drug that inhibits the growth of cancer cells. It has shown promising results in the treatment of bowel diseases and may be a candidate for normalizing bowel motility in patients with irritable bowel syndrome. LZP also has antiinflammatory effects, which may be due to its ability to inhibit cytokine production.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 366.29 g/mol
• Formule: C₁₆H₁₃F₃N₄O₃
• Degré de pureté: Min. 95%